We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $111M
1-Year Est. Return 22.51%
This Fund
S&P 500
This Quarter Est. Return
-3.24%
1 Year Est. Return
+22.51%
3 Year Est. Return
+52.19%
5 Year Est. Return
10 Year Est. Return
AUM
$104M
AUM Growth
-$6.47M
Cap. Flow
-$1.26M
Cap. Flow %
-1.2%
Top 10 Hldgs %
22.84%
Holding
65
New
3
Increased
2
Reduced
55
Closed
3

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$2.01M
2
UNM icon
Unum
UNM
+$1.83M
3
SIRI icon
SiriusXM
SIRI
+$1.28M
4
BMY icon
Bristol-Myers Squibb
BMY
+$387K
5
PFG icon
Principal Financial Group
PFG
+$233K

Sector Composition

Rank Sector Weight
1 Financials 25.22%
2 Healthcare 13.21%
3 Industrials 11.88%
4 Technology 9.53%
5 Energy 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORI icon
1
Old Republic International
ORI
$9.98B
$2.55M 2.44%
70,486
-1,788
-2% -$65.2K
AVGO icon
2
Broadcom
AVGO
$1.65T
$2.53M 2.42%
10,932
-3,969
-27% -$734K
PKG icon
3
Packaging Corp of America
PKG
$20.8B
$2.49M 2.39%
11,080
-353
-3% -$81.7K
CMI icon
4
Cummins
CMI
$74.5B
$2.45M 2.34%
7,015
-173
-2% -$60.8K
AMP icon
5
Ameriprise Financial
AMP
$49.3B
$2.37M 2.27%
4,449
-574
-11% -$306K
JPM icon
6
JPMorgan Chase
JPM
$931B
$2.34M 2.24%
9,749
-251
-3% -$58.5K
AFL icon
7
Aflac
AFL
$58.7B
$2.32M 2.22%
22,407
-557
-2% -$60.7K
CINF icon
8
Cincinnati Financial
CINF
$26.4B
$2.29M 2.19%
15,925
-393
-2% -$57.4K
SNA icon
9
Snap-on
SNA
$19.5B
$2.28M 2.19%
6,728
-168
-2% -$56.7K
PRU icon
10
Prudential Financial
PRU
$41.2B
$2.24M 2.15%
18,922
-477
-2% -$58.9K
MSFT icon
11
Microsoft
MSFT
$3.75T
$2.23M 2.13%
5,290
-129
-2% -$54.9K
SCHW
12
Charles Schwab
SCHW
$186B
$2.21M 2.12%
29,846
-763
-2% -$57.1K
KR icon
13
Kroger
KR
$36.3B
$2.2M 2.1%
35,952
-902
-2% -$52.9K
GILD icon
14
Gilead Sciences
GILD
$182B
$2.19M 2.09%
23,655
-613
-3% -$55.2K
LOW icon
15
Lowe's Companies
LOW
$111B
$2.12M 2.03%
8,574
-216
-2% -$57.7K
MET icon
16
MetLife
MET
$62.1B
$2.11M 2.02%
25,810
-641
-2% -$53.3K
NEE icon
17
NextEra Energy
NEE
$170B
$2.05M 1.96%
28,535
-709
-2% -$55.1K
ABBV icon
18
AbbVie
ABBV
$463B
$2.03M 1.95%
11,436
-276
-2% -$50.7K
LMT icon
19
Lockheed Martin
LMT
$122B
$2.03M 1.95%
4,184
-102
-2% -$55.6K
GD icon
20
General Dynamics
GD
$96.5B
$2.01M 1.92%
7,632
-189
-2% -$54.4K
UNM icon
21
Unum
UNM
$15B
$1.94M 1.85%
+26,488
New +$1.83M
ITW icon
22
Illinois Tool Works
ITW
$76.6B
$1.92M 1.84%
7,565
-195
-3% -$51.7K
TGT icon
23
Target
TGT
$72.1B
$1.86M 1.78%
13,755
-346
-2% -$49.6K
ENB icon
24
Enbridge
ENB
$105B
$1.82M 1.74%
42,879
-1,080
-2% -$45.2K
WTRG icon
25
Essential Utilities
WTRG
$11.8B
$1.8M 1.72%
49,508
-1,234
-2% -$47.9K

Similar funds

Weaver C. Barksdale & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Weaver C. Barksdale & Associates held 65 positions worth $104M, down 5.8% from $111M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Weaver C. Barksdale & Associates's Q4 2024 filing shows 3 new, 2 increased, 55 reduced and 3 closed positions. Its largest new stake was Elevance Health: 4,803 shares worth $1.77M. The largest sale was Interpublic Group of Companies, an estimated $1.56M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q4 2024 buy was Elevance Health: 4,803 shares worth $1.77M.
  • Weaver C. Barksdale & Associates added most to Bristol-Myers Squibb in Q4 2024, an estimated $387K increase.
  • Weaver C. Barksdale & Associates's biggest Q4 2024 reduction was Broadcom, cutting an estimated $734K.
  • Weaver C. Barksdale & Associates fully exited Interpublic Group of Companies in Q4 2024, selling an estimated $1.56M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 23% of its $104M portfolio in Q4 2024.
  • Weaver C. Barksdale & Associates opened 3 new positions and closed 3 in Q4 2024.
  • Weaver C. Barksdale & Associates's portfolio value fell 5.8% quarter-over-quarter to $104M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.